- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05771350
Online Hemodiafiltration Versus Hemodialysis in Removal of Indoxyl Sulfate in Chronic Hemodialysis Patients
March 5, 2023 updated by: Mohamed sary gharib, Ain Shams University
Hemodiafiltration Versus Hemodialysis in Removal of Indoxyl Sulfate in Chronic Hemodialysis Patients
this study aimed to compare the removal of indoxyl sulphate between hemodiafiltration, high flux hemodialysis and low flux hemodialysis
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- maintenance hemodialysis patients aged more than 18 years
Exclusion Criteria:
- active illnesses, hospitalization, malignancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: online hemodiafiltration
|
20 patients on regular hemodialysis received online hemodiafiltration
|
|
Active Comparator: high flux hemodialysis
|
20 patients on regular hemodialysis received high flux hemodialysis
|
|
Active Comparator: low flux hemodialysis
|
20 patients on regular hemodialysis received low flux hemodialysis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
dialytic removal of indoxyl sulpahte
Time Frame: one month when all samples were collected
|
assessed by the reduction ration of indoxyl sulphate
|
one month when all samples were collected
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 15, 2016
Primary Completion (Actual)
January 15, 2017
Study Completion (Actual)
January 15, 2017
Study Registration Dates
First Submitted
March 5, 2023
First Submitted That Met QC Criteria
March 5, 2023
First Posted (Actual)
March 16, 2023
Study Record Updates
Last Update Posted (Actual)
March 16, 2023
Last Update Submitted That Met QC Criteria
March 5, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- FMASU MD 301/2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemodialysis
-
National Taiwan University HospitalCompletedHemodialysis Complication | Hemodialysis-Induced SymptomTaiwan
-
University Hospital, GhentEnrolling by invitationPediatric | Efficiency | Hemodialysis Treatment | Hemodialysis PatientBelgium
-
Khon Kaen UniversityCompletedHemodialysis | Hemodialysis Treatment | Dialysis AdequacyThailand
-
Vantive Health LLCBaxter Healthcare Corporation; Gambro Renal Products, Inc.Completed
-
Osaka UniversityCompleted
-
Chinese PLA General HospitalWithdrawn
-
University of HyogoCompleted
-
DVX, LLCNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Renal...Completed
-
Dong-A UniversityCompletedHemodialysisKorea, Republic of
Clinical Trials on online hemodiafiltration
-
University of NottinghamFresenius Medical Care Deutschland GmbHCompletedMyocardial Perfusion | Other Postprocedural Cardiac Functional Disturbances
-
Korean Hemodialysis Study GroupBoryung Pharmaceutical Co., LtdUnknown
-
Instituto Nacional de Ciencias Medicas y Nutricion...Not yet recruitingHemodialysis | End Stage Renal Disease (ESRD) | Renal Dialysis | Hemodiafiltration | Chronic Kidney Disease on Hemodialysis | Uremia; ChronicMexico
-
Seoul National University HospitalSamsung Medical Center; Seoul St. Mary's Hospital; Baxter Healthcare Corporation and other collaboratorsCompletedKidney Failure, Chronic | Renal DialysisKorea, Republic of
-
A. Manzoni HospitalCompleted
-
Centre hospitalier de l'Université de Montréal...CompletedAcute Kidney InjuryCanada, Ireland
-
Mahidol UniversityActive, not recruiting
-
Pontifícia Universidade Católica do ParanáFresenius AGCompletedChronic Kidney DiseaseBrazil
-
University of Sao PauloCompletedHemodialysis-Induced Symptom | Dialysis Related Complication | Dialysis HypotensionBrazil
-
Kantonsspital AarauFresenius Medical Care Deutschland GmbHCompletedRenal Failure Chronic Requiring HemodialysisSwitzerland